Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-06-04 @ 7:05 PM
Study NCT ID:
NCT03836157
Status:
WITHDRAWN
Last Update Posted:
2019-06-27
First Post:
2019-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer
Sponsor:
University of Oklahoma
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OUSCC-IMGN-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |